The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- Football : Bundesliga scores points but does not win the match May 18, 2020
- Gunter Rave Reveals They Already Scheduled Their COVID-19 Vaccination: “I’m Excited” Jun 30, 2021
- Medically high risk 16-18 year olds will soon receive the first vaccine Apr 19, 2021
- 82-year-old man’s wrong leg is mistakenly amputated May 29, 2021
- The devil is in the detail : and if the silence of Discovery was the missing piece of the puzzle? Jun 3, 2020
- Woman needs eye removal: new accusation of negligence plagues Valdivia Hospital Nov 12, 2022
- The immunologist predicted the beginning of the fourth wave of COVID-19 in Russia Sep 15, 2021